Ab­b­Vie/Roche's Ven­clex­ta wins fourth ap­proval; WuXi, fel­low CRO Al­ta­sciences ink deal

Ab­b­Vie and Roche’s blood can­cer drug, Ven­clex­ta, has notched a fourth ap­proval. On Wednes­day, Ab­b­Vie $AB­BV said the drug was ap­proved in com­bi­na­tion with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.